cox 189 has been researched along with Coxarthrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dattani, ID; Maxwell, T; Moore, A; Rebuli, R; Sallstig, P; Schneider, H; Schnitzer, TJ; Seriolo, B; Tseng, L | 1 |
| Beier, J; Geusens, P; Gitton, X; Hasler, P; Moore, A; Patel, SK; Poór, G; Schnitzer, TJ; Senftleber, I; Sloan, VS | 1 |
2 trial(s) available for cox 189 and Coxarthrosis
| Article | Year |
|---|---|
A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Pain; Pain Measurement; Treatment Outcome | 2011 |
Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Topics: Aged; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Organic Chemicals; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain; Placebos; Surveys and Questionnaires; Treatment Outcome | 2004 |